REaCT 5G: A randomized study comparing bone pain after 5 days of filgrastim or one day of pegfilgrastim for primary febrile neutropenia prophylaxis during neo-/adjuvant chemotherapy for early breast cancer

被引：0
|
作者：
Terry Ng
Zhang, Yuxin
Stober, Carol
Shamess, Jennifer
Mills, Natalie
Nicholls, Stuart
Ibrahim, Mohammed
Davoudpour, Daniel
Armiento, Christopher
Savard, Marie-France
Rushton, Moira
Awan, Arif
Sehdev, Sandeep
Hilton, John
Song, Xinni
Goel, Rakesh
Macdonald, Fiona
Daigle, Kelly
Vandermeer, Lisa
Taljaard, Monica
Clemons, Mark
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO2-12-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO2-12-12
引用
收藏
页数：4
相关论文
共 2 条
  • [1] A randomized, multicenter pragmatic trial comparing bone pain from a single dose of pegfilgrastim to 5 doses of daily filgrastim in breast cancer patients receiving neoadjuvant/adjuvant chemotherapy (REaCT-5G)
    Ng, Terry L.
    Taljaard, Monica
    Savard, Marie-France
    Stober, Carol
    Nicholls, Stuart
    Vandermeer, Lisa
    Thavorn, Kednapa
    Hampel, Claudia
    Shamess, Jennifer
    Mills, Natalie
    Hilton, John F.
    Clemons, Mark
    CANCER RESEARCH, 2022, 82 (04)
  • [2] A pilot study of single pegfilgrastim compared with intermittent every other days of 5 shot-filgrastim in breast cancer patients receiving adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapy (G-CSF 105 trial: NCT02685111)
    Jeong, J.
    Sohn, B. S.
    Ahn, J-H.
    Jung, K. H.
    Kim, J. E.
    Oh, J.
    Lee, H.
    Sohn, J. H.
    Koh, S-J.
    Seo, J. H.
    Lee, K. S.
    Kim, S-B.
    ANNALS OF ONCOLOGY, 2018, 29 : 5 - 5
1